Consumables Uptick Drives Newly Public NanoString Q2 Revenues up 22 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – NanoString Technologies said after the close of the market on Tuesday that revenues for its second quarter rose 22 percent year over year.

The Seattle-based company, which went public in late June, raising $47.0 million in net proceeds, reported revenues of $7.2 million for the three months ended June 30, compared to $5.9 million a year ago, and beating the average Wall Street estimate of $6.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.